Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia

NCT00066248 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT00066248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00066248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Cyproheptadine Hydrochloride (Periactin) and Megestrol Acetate (Megace) on Weight in Children With Cancer/Treatment Related Cachexia
Lead sponsor
University of South Florida
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
August 31, 2007
Enrollment
70 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, cachexia, central nervous system tumors, leukemia, lymphoma, myelodysplastic syndromes, myelodysplastic/myeloproliferative diseases, unspecified childhood solid tumor, protocol specific